New weight loss drug shows promise for Type 2 Diabetes patients
A new clinical trial suggests retatrutide could become a major breakthrough treatment for obesity and Type 2 diabetes. A new Phase 3 clinical trial by Eli Lilly and Company found that its experimental drug retatrutide helped adults with Type 2 diabetes lose significant weight while improving blood sugar control. Researchers said patients taking the highest…